Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research...
Read moreCardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research...
Read moreWest High Yield (W.H.Y.) Resources Ltd. (TSXV: WHY) (‘West High Yield’ or the ‘Company’) announces that, further to its news...
Read more(TheNewswire) Vancouver, British Columbia The Newswire October 11, 2024 Hertz Energy Inc. (CSE: HZ; OTCQB: HZLIF; FSE: QE2) (the ‘...
Read moreSuki AI, a healthcare-focused startup, has secured US$70 million in a Series D funding round aimed at further developing its...
Read moreNot for distribution to U.S. news wire services or for dissemination in the United States or to a U.S. Person....
Read moreThe S&P/TSX Venture Composite Index (INDEXTSI:JX) was up 0.96 percent on the week to 595.59 by 12:00 p.m. EDT on...
Read moreThe Royal Swedish Academy of Sciences recognized advancements in artificial intelligence (AI) this week, handing out two prizes to researchers...
Read moreFor visually impaired sports fans at stadiums around the world, following a match often means relying on commentators or those...
Read moreSixty-five more women have come forward with abuse allegations against the late billionaire Mohamed Al Fayed, according to the BBC,...
Read moreBritain’s Prince and Princess of Wales made a surprise visit to Southport, northwest England, on Thursday, where they met the...
Read moreDisclaimer: financemasterynews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.